DEDUCCIONES SEPT 11

More documents

Recommendations

Info

$tipos de reducciÃ³n de una fractura$

LISTADO DE MEDICAMENTOS AFECTADOS POR LAS DEDUCCIONES DEL REAL DECRETO-LEY 8/2010 - SEPTIEMBRE 2011CODIGONACIONAL NOMBRE PRESENTACION HUERFANO DEDUCCION870519 OPIREN FLAS 15 mg comprimidos bucodispersables , 28 comprimidos 7,50%870667 FREEFLEX GLUCOSA 5% Solucion para perfusion , 50 ml 7,50%870675 FREEFLEX GLUCOSA 5% Solucion para perfusion , 100 ml 7,50%871079 NORMULEN , 40 comprimidos 7,50%871988 CELEBREX 200 mg capsulas duras , 30 capsulas 7,50%Physioneal 40 Glucosa 3,86% p/v 38,6 mg/ml sol. dialisis peritoneal, 1,5 l872226 (doble bolsa con. punzon) 7,50%872622 OPIREN FLAS 30 mg Comprimidos bucodispersables, 28 comprimidos 7,50%872788 FLOGOTER 25 mg capsulas, 20 capsulas 7,50%872820 TEDIPRIMA 160 mg capsulas, 16 capsulas 7,50%872838 TEDIPRIMA suspension , botella de 100 ml 7,50%873018 PEGINTRON 50MCG 1VIAL+1AMP+1JER+2AGU+1TOAL 7,50%873141 OMACOR 1000 mg capsulas blandas , 28 capsulas 7,50%873166 OMACOR 1000 mg capsulas blandas , 100 capsulas 7,50%873224 CERTICAN 0,25 MG COMPRIMIDOS, 60 comprimidos 7,50%873471 FENITOINA RUBIO, 1 ampolla de 2 ml 7,50%873521 CONDRODIN 400 GRANULADO PARA SOLUCION ORAL 60 7,50%873539 CONDRODIN 400 CAPSULAS 60 7,50%873695 XILONIBSA 2% con epinefrina 1,8 ml , 1 cartucho de 1,8 ml 7,50%873851 MITOMYCIN-C 2 mg Polvo para solucion inyectable , 1 vial de 2 mg 7,50%873869 MITOMYCIN-C 2 mg Polvo para solucion inyectable , 10 viales de 2 mg 7,50%874230 SCANDINIBSA 2% 1 x 1,8 ml 7,50%874263 SCANDINIBSA 30 mg/ml solucion inyectable , 1 cartucho de 1,8 ml 7,50%874347 CERTICAN 0,25 MG COMPRIMIDOS DISPERSABLES, 60 comprimidos 7,50%874354SERETIDE 25/50 microgramos suspension para inhalacion en envase apresion , 1 inhalador de 120 dosis 7,50%874438DOBUCOR 50 mg/ml concentrado para solucion para perfusion, 5 ampollascon 5 ml 7,50%874453 INIBSACAIN 0,5% PLUS solucion inyectable, 2 ampollas de 10 ml 7,50%874461 INIBSACAIN 0,25% PLUS solucion inyectable, 2 ampollas de 10 ml 7,50%874578SERETIDE 25/125 microgramos suspension para inhalacion en envase apresion , 1 inhalador con 120 aplicaciones 7,50%874586SERETIDE 25/250 microgramos suspension para inhalacion en envase apresion , 1 inhalador de 120 aplicaciones 7,50%
LISTADO DE MEDICAMENTOS AFECTADOS POR LAS DEDUCCIONES DEL REAL DECRETO-LEY 8/2010 - SEPTIEMBRE 2011CODIGONACIONAL NOMBRE PRESENTACION HUERFANO DEDUCCION874719BRISAIR 25/50 microgramos suspension para inhalacion en envase apresion, 1 x 120 dosis 7,50%874735 BRISAIR 25/125MCG 1 INHALADOR 120 APLIC 7,50%874776 TANAKENE solucion oral , 50 ml 7,50%874792 NAROPIN POLYAMP 50 mg intratecal solucion inyectable 5 x 10 ml 7,50%BERIATE P 500 UI polvo y disolvente para solucion para inyeccion o875021 perfusion, 1 VIAL 5ML 7,50%875039 EPISTAXOL 10ML SOLUCION TOPICA 7,50%BERIATE P 1000 UI polvo y disolvente para solucion para inyeccion o875047 perfusion,1 INYECTABLE 10ML 7,50%875104 INDONILO capsulas, 24 capsulas 7,50%875112 INDONILO capsulas, 48 capsulas 7,50%875120 INDONILO 100MG 12 SUPOSITORIOS 7,50%BRISAIR 25/250 microgramos suspension para inhalacion en envase a875369 presion , 1 x 120 dosis 7,50%875377 RHODOGIL comprimidos, 30 comprimidos 7,50%875393 CERTICAN 0,5 MG COMPRIMIDOS, 60 comprimidos 7,50%NORMOSANG 25 mg/ml concentrado para solucion para perfusion , 4875484 ampollas de 10 ml 7,50%875815 HUMALOG Mix25 Pen 100 U/ml suspension inyectable 5 7,50%875831 DIDRICA 8G GRANULADO 4 SOBRES 7,50%875849 HUMALOG Mix50 Pen 100 U/ml suspension inyectable 5 7,50%875856 HUMALOG BASAL Pen 100 U/ml suspension inyectable 5 7,50%875880 PHARKEN 0,05 mg, 30 COMPRIMIDOS 7,50%875898 PHARKEN 0,05 mg, 50 COMPRIMIDOS 7,50%876029 RAPAMUNE 5MG/5ML 60ML 1 BOTELLA SOLUCION ORAL 7,50%876367 PHARKEN 0,25 mg, 30 comprimidos 7,50%876375 PHARKEN 0,25 mg, 50 comprimidos 7,50%876383 GENOXAL 200 mg inyectable 1 x 20 ml 7,50%876458 VISCOFRESH 0,5%, 10 viales de 0,4 ml 7,50%876466 VISCOFRESH 0,5%, 30 viales de 0,4 ml 7,50%877076 ANALGIPLUS, 20 comprimidos 7,50%877316 VERNIES comprimidos , 30 comprimidos 7,50%877472 CERTICAN 0,75 MG COMPRIMIDOS, 60 comprimidos 7,50%
Page 1 and 2:
LISTADO DE MEDICAMENTOS AFECTADOS P
Page 3 and 4:
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215: LISTADO DE MEDICAMENTOS AFECTADOS P
Page 314 and 315:
Page 316 and 317:
show all

DEDUCCIONES SEPT 11

Create successful ePaper yourself

Delete template?

Save as template?